[go: up one dir, main page]

ATE315789T1 - Elisa für vegf - Google Patents

Elisa für vegf

Info

Publication number
ATE315789T1
ATE315789T1 AT00978702T AT00978702T ATE315789T1 AT E315789 T1 ATE315789 T1 AT E315789T1 AT 00978702 T AT00978702 T AT 00978702T AT 00978702 T AT00978702 T AT 00978702T AT E315789 T1 ATE315789 T1 AT E315789T1
Authority
AT
Austria
Prior art keywords
vegf
diagnostic
prognostic index
elisa
pathologies
Prior art date
Application number
AT00978702T
Other languages
English (en)
Inventor
David Tai Wai Fei
Kristen K Tomita
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE315789T1 publication Critical patent/ATE315789T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT00978702T 1999-11-16 2000-11-15 Elisa für vegf ATE315789T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16573699P 1999-11-16 1999-11-16

Publications (1)

Publication Number Publication Date
ATE315789T1 true ATE315789T1 (de) 2006-02-15

Family

ID=22600234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978702T ATE315789T1 (de) 1999-11-16 2000-11-15 Elisa für vegf

Country Status (14)

Country Link
US (2) US6855508B2 (de)
EP (1) EP1230552B1 (de)
JP (1) JP4620312B2 (de)
KR (1) KR100749982B1 (de)
CN (1) CN100399030C (de)
AT (1) ATE315789T1 (de)
AU (1) AU774575C (de)
CA (1) CA2387390C (de)
DE (1) DE60025526T2 (de)
ES (1) ES2256066T3 (de)
IL (2) IL149171A0 (de)
NZ (1) NZ518363A (de)
WO (1) WO2001036972A2 (de)
ZA (1) ZA200202942B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60025526T2 (de) * 1999-11-16 2006-08-24 Genentech, Inc., South San Francisco Elisa für vegf
AU2002234080A1 (en) * 2000-10-20 2002-04-29 Baylor College Of Medecine Methods for detecting retinopathy of prematurity
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
JP2007501011A (ja) * 2003-08-01 2007-01-25 ジェネンテック・インコーポレーテッド 制限多様性配列を有する結合型ポリペプチド
US7758859B2 (en) 2003-08-01 2010-07-20 Genentech, Inc. Anti-VEGF antibodies
US20050106667A1 (en) 2003-08-01 2005-05-19 Genentech, Inc Binding polypeptides with restricted diversity sequences
US7514223B2 (en) 2004-05-15 2009-04-07 Genentech, Inc. Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
CA2511269A1 (en) * 2004-07-07 2006-01-07 F. Hoffmann-La Roche Ag Multimarker panel based on p1gf for diabetes type 1 and 2
CN1316249C (zh) * 2004-08-25 2007-05-16 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及制备方法
US7595149B1 (en) 2004-11-08 2009-09-29 University Of Kentucky Research Foundation Methods for cancer detection
AU2013221919B2 (en) * 2006-10-04 2016-04-14 Genentech, Inc. ELISA for VEGF
PL2457929T3 (pl) 2006-10-04 2016-12-30 Test ELISA dla VEGF
WO2008079322A1 (en) * 2006-12-22 2008-07-03 Beckman Coulter, Inc. Methods, kits and materials for diagnosing disease states by measuring isoforms or proforms of myeloperoxidase
US20080160638A1 (en) * 2006-12-27 2008-07-03 David Lederman Functionalized Microcantilever Sensor and Associated Method For Detection of Targeted Analytes
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
TWI468417B (zh) 2007-11-30 2015-01-11 Genentech Inc 抗－ｖｅｇｆ抗體
CN102016552A (zh) * 2008-03-05 2011-04-13 神谷来克斯公司 用于分子的高灵敏性检测的方法和组合物
US7772006B2 (en) 2008-08-21 2010-08-10 Paul Tornambe Agent detection and/or quantitation in a biological fluid
US20100086951A1 (en) 2008-09-04 2010-04-08 Beckman Coulter, Inc. Pan-Kinase Activation and Evaluation of Signaling Pathways
CA2741117A1 (en) * 2008-10-30 2010-05-06 Centre De Recherche Public De La Sante Biomarkers for heart failure
US8349325B2 (en) * 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
EP2488661B1 (de) 2009-10-14 2014-12-24 Oberbauer, Rainer Prüfung auf Risiko einer akuten Nierenverletzung
WO2011057347A1 (en) 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
US20120004132A1 (en) * 2010-07-02 2012-01-05 Affymetrix, Inc. Detection of Nucleic Acids and Proteins
CN104730243A (zh) 2010-07-19 2015-06-24 霍夫曼-拉罗奇有限公司 鉴定响应抗癌疗法的可能性升高的患者的方法
MX2013000667A (es) 2010-07-19 2013-02-27 Hoffmann La Roche Metodo para identificar pacientes con probabilidad incrementada de responder a una terapia anticancer.
EP2606362B1 (de) 2010-08-19 2015-09-30 Roche Diagniostics GmbH Assay zur messung der antikörperbindung an einen therapeutischen, monoklonalen antikörper
WO2012030738A2 (en) 2010-08-30 2012-03-08 Beckman Coulter, Inc. Complex phosphoprotein activation profiles
WO2012098203A1 (en) * 2011-01-21 2012-07-26 Basilea Pharmaceutica Ag Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
WO2012113718A1 (en) 2011-02-21 2012-08-30 Roche Diagnostics Gmbh A diagnostic method for type ii diabetes
EP2786148A4 (de) * 2011-03-31 2015-12-16 Tgr Biosciences Pty Ltd Nachweis von analyten mit einem einschritt-immuntest
CN102323421A (zh) * 2011-05-24 2012-01-18 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及其制备方法
FR2976076B1 (fr) * 2011-05-31 2015-02-27 Imabiotech Procede de detection et de quantification d'une molecule cible dans un tissu
CN102435743B (zh) * 2011-09-15 2014-10-15 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及其制备方法
US20130149386A1 (en) * 2011-12-07 2013-06-13 Region Nordjylland Cd36 as biomarker for steatosis
BR112014011535A2 (pt) 2011-12-19 2017-05-09 Hoffmann La Roche método para a determinação in vitro e imunológica de presença da presença e/ou da quantidade de um parceiro de ligação, método in vitro e utilização de um anticorpo
MX349661B (es) * 2012-02-01 2017-08-08 Hoffmann La Roche Metodo para la deteccion de una molecula de union de un enlazador multiespecifico.
CN104471397B (zh) 2012-07-13 2018-03-23 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的方法
WO2014122166A1 (en) 2013-02-06 2014-08-14 Pieris Ag Novel lipocalin-mutein assays for measuring hepcidin concentration
CN106153934B (zh) * 2015-03-26 2018-06-19 广州瑞博奥生物科技有限公司 一种高效定量检测高尔基体73的试剂盒
CN106153933B (zh) * 2015-03-26 2018-09-04 广州瑞博奥生物科技有限公司 一种高效定量检测c反应蛋白的免疫学试剂盒
CN106153935B (zh) * 2015-03-26 2018-05-08 广州瑞博奥生物科技有限公司 一种定量检测CD79α的酶联免疫试剂盒
UA125432C2 (uk) 2015-09-23 2022-03-09 Дженентек, Інк. Оптимізовані варіанти анти-vegf антитіл
CN105353136A (zh) * 2015-12-01 2016-02-24 北京健平九星生物医药科技有限公司 基于量子点CdSe检测人血清中VEGF浓度的试剂盒及其使用方法
EP3485281A1 (de) 2016-07-15 2019-05-22 H. Hoffnabb-La Roche Ag Verfahren und mittel zur erkennung der stufe des gesamten vegf-a
US11185552B2 (en) 2016-11-16 2021-11-30 Ichor, Llc Inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions
CN107677808A (zh) * 2017-08-04 2018-02-09 苏州浩欧博生物医药有限公司 一种甲状腺球蛋白的定量检测试剂盒及其制备方法和检测方法
CN111808191A (zh) * 2020-05-11 2020-10-23 廊坊天光生物技术有限公司 一种用于检测血清中vegf含量的抗体对及其用途
JP7485273B2 (ja) 2020-06-25 2024-05-16 国立大学法人 鹿児島大学 抗ｖｅｇｆ－ａ抗体による癌に対する治療応答性を予測又は決定するための方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (de) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
CA1023287A (en) 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
US4195128A (en) 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
US4229537A (en) 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
IT8423926U1 (it) * 1984-11-29 1986-05-29 Ire Ind Riunite Eurodomestici S P A Disposizione per rimuovere detersivi e prodotti di lavaggio in genere dagli scomparti dei cassetti di macchine lavabiancheria domestiche
US5620845A (en) 1988-06-06 1997-04-15 Ampcor, Inc. Immunoassay diagnostic kit
US5219739A (en) 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
FI922164A7 (fi) 1990-09-14 1992-05-13 Biosite Diagnostics Inc Ligandireseptorien ja ligandien muodostamia komplekseja vastaan suunna ttuja vasta-aineita ja niiden käyttö ligandi-reseptori-määrityksissä
US5434087A (en) 1993-02-24 1995-07-18 Abbott Laboratories Folate immunoassay utilizing folate binding protein in a multiclonal antibody format
AU696764B2 (en) * 1994-03-08 1998-09-17 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
JPH08245424A (ja) * 1995-03-06 1996-09-24 Toagosei Co Ltd 糖尿病性腎症診断剤
JP3591264B2 (ja) * 1997-12-24 2004-11-17 富士レビオ株式会社 Ｖｅｇｆ１２１特異的モノクローナル抗体及び測定方法
DE60025526T2 (de) * 1999-11-16 2006-08-24 Genentech, Inc., South San Francisco Elisa für vegf

Also Published As

Publication number Publication date
ZA200202942B (en) 2003-06-25
CA2387390A1 (en) 2001-05-25
KR100749982B1 (ko) 2007-08-16
US20030044865A1 (en) 2003-03-06
AU1613401A (en) 2001-05-30
DE60025526T2 (de) 2006-08-24
IL149171A (en) 2008-06-05
US20070202558A1 (en) 2007-08-30
WO2001036972A3 (en) 2002-01-03
KR20020070434A (ko) 2002-09-09
DE60025526D1 (de) 2006-04-06
WO2001036972A2 (en) 2001-05-25
EP1230552A2 (de) 2002-08-14
CN1420987A (zh) 2003-05-28
JP4620312B2 (ja) 2011-01-26
CA2387390C (en) 2009-01-06
IL149171A0 (en) 2002-11-10
JP2003515136A (ja) 2003-04-22
EP1230552B1 (de) 2006-01-11
US6855508B2 (en) 2005-02-15
ES2256066T3 (es) 2006-07-16
US7541160B2 (en) 2009-06-02
CN100399030C (zh) 2008-07-02
AU774575B2 (en) 2004-07-01
NZ518363A (en) 2003-01-31
AU774575C (en) 2005-09-08

Similar Documents

Publication Publication Date Title
DE60025526D1 (de) Elisa für vegf
MX2009003562A (es) Ensayo elisa para la deteccion de vegf.
ATE348843T1 (de) Nachweis von tsh-rezeptor-autoantikörpern mit affinitätsgereinigten antikörpern
NO904001D0 (no) Fremgangsmaate og anordning for amperometrisk diagnoseanalyse.
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
WO2005108989A3 (en) Assay for antibodies
WO2001040517A3 (en) Evaluating and predicting clinical outcomes by gene expression analysis
CN101025415A (zh) 一种检测尿液中尿酸含量范围的试纸
NO953770L (no) Analysemetode
DE3870405D1 (de) Testvorrichtung zur bestimmung von okkultem blut und glukose.
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
Hemphill Tooth size apportionment among contemporary Indians: An analysis of caste, language, and geography.
Hu et al. Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques
RU96121426A (ru) Способ диагностики опийной наркомании
EP0232706A3 (de) Blutgruppe-Antigen-Platte
FR2840905B1 (fr) Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
RU2003125666A (ru) Способ диагностики рака предстательной железы
SE9403953D0 (sv) Sequence-based diagnosis
DE69221104D1 (de) Immunoassay für NCA-BT in Blutproben von Brustkrebspatientinnen
RU2314040C1 (ru) Способ диагностики острого пиелонефрита у детей
Stamler et al. More on dietary sodium and blood pressure
Goodson Application of expanded polytetrafluoroethylene (ePTFE) tubing to the study of human wound healing

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1230552

Country of ref document: EP